hcp.obgyn.net Members: Login | Register
OBGYN.net Recommended Medical Sites Medline Drugs

Powered by SearchMedica

 
  • Home
  • News
  • Blogs
  • Calendar
  • Conditions and Procedures
  • Conferences
  • Tutorials
  • Forum
  • Ultrasound
  • Buyer's Guide
Home » All Topics » Fetal Monitoring

OBGYN.net.
 

CARDIOTOCOGRAPHY

By Herman P. van Geijn, MD PhD
Dept. of Obstetrics and Gynaecology, Academic Hospital Vrije Universiteit | July 21, 2011

 

Published in:
Textbook of Perinatal Medicine
Editor-in-Chief Asim Kurjak
Parthenon Publishing, 1998
Vol. 2: 1424-8

 

INTRODUCTION

Until the second half of the 20th century assessment of the fetal condition depended on very limited means: the growth of the uterus and its contents, the movements of the fetus perceived by the mother and the listening of the fetal heart beat with a mono- or binaural stethoscope (1). Sudden absence of fetal movements in the second half of pregnancy was, at that time, not only a very emotional but also a serious diagnostic problem. Usually one had to wait for some weeks in order to observe if the uterus would grow before the decision could be reached to induce labour. The sign of Spalding at X-ray examination, showing overlapping of the fetal skull bones like roof tiles as a result of advanced maceration of the fetal tissues, was one of the few helpful objective diagnostic signs of fetal demise.

This recurrent dilemma, whether or not the fetus had died in utero, formed the major impulse for the development of cardiotocography (2). Initially fetal abdominal electrocardiography and phonocardiotocography were pursued, but failed, primarily due to technical problems.

It was only when the fetal heart beat could be rather easily detected by means of ultrasound (the Doppler-shift) or through the application of direct electrocardiography, that cardiotocography became popular as the method to monitor the condition of the fetus. Currently the majority of obstetric decisions to assist delivery of the baby by artificial means (caesarean section, forceps or vacuum extraction) for reasons of suspected fetal distress, relies on information gathered through the application of cardiotocography.

It is the obstetrician’s reassurance that the fetal heart rate (FHR) pattern is normal and the nearly 100% certainty that the fetus is in a good condition, which has made cardiotocography so attractive and has induced its widespread use. This development is very understandable considering the dependence on indirect signals from the fetus and the problems mentioned in the first paragraph concerning the very limited means to monitor the condition of the fetus prior to the introduction of cardiotocography. However, now cardiotocography is in use for some decades criticism towards the method itself and objections to its widespread application are increasing (table 1). These criticisms and objections will be discussed in more detail and it will be tried to reach a more differentiated opinion.

THE NORMAL AND ABNORMAL FHR PATTERN

The normal fetal heart rate (FHR) pattern is characterised by a baseline frequency between 110 and 150 beats per minute, presence of periodic accelerations, a normal heart rate variability with a bandwidth between 5 and 25 beats per minute and the absence of decelerations (3). In this regard the accentuation of the 120 and 160 frequencies is misleading. It originates from the second half of the 19th century when the normal frequencies by Von Winckel were stated to be between 120 and 160 beats per minute.

The FHR pattern is abnormal when one or more of the following features are observed: a baseline frequency below 110 or above 150 beats per minute, absence of accelerations for more than 45 minutes, decreased or absent FHR variability and the existence of repeated variable or late decelerations. A baseline frequency between 100 and 110 can be considered as normal when the duration of pregnancy has exceeded 41 weeks.

ARE THE CRITICISMS ON CARDIOTOCOGRAPHY JUSTIFIED?

In recent years cardiotocography has been criticised for a number of reasons. A far from complete summary is given in table 1. The criticisms have a very diverging character. Each of them will be commented on in the following paragraphs.

The FHR pattern is a too indirect signal of the fetal condition

The (patho-)physiologic background of the fetal heart rhythm is extremely complex (4). Blood pressure, cardiovascular regulation, the condition of the autonomic and voluntary central and peripheral nervous system, respiration, temperature regulation, the renin-angiotensin system, the functioning of the adrenals, endocrine mechanisms, the cardiac conduction systems, the condition of the vessel walls and cellular processes, all contribute to the shape of the heart rate pattern recorded on paper or a visual screen. Under normal circumstances the FHR pattern primarily represents the state of the central nervous system, i.e. the 24-hour (circadian) rhythms and the cycling of behavioural states (ultradian rhythms). When the condition of the fetus is being threatened there is a shift to a more likely representation of disturbances in the regulation of the blood pressure and the cardiac performance, and ultimately a direct influence on the fetal heart.

Artificial occlusions of the umbilical cord circulation and the uterine circulation in animal experiments have contributed to a better understanding of the various aspects of the fetal heart rate pattern under pathologic circumstances. The human situation is far more complex though. Successive uterine contractions vary in duration and intensity. The position of the human fetus may change. The amount of amniotic fluid varies from fetus to fetus. Occlusions of the uterine circulation, umbilical vessels and/or placental circulation can be absent, be partial or even be total. The circulation in the umbilical vein and/or one or both umbilical arteries can be affected. These are just a few of the many combinations on the circulatory level that may occur when the fetal condition is threatened. Next there are the many complex variations regarding the biochemical status of the fetus, in particular the state of the acid-base balance. It should be remembered that depth, duration and shape of variable decelerations have no direct relation to the acid-base balance of the fetus at a particular moment (5).

Differences in techniques

For a correct understanding of the FHR pattern as recorded on paper or a screen it is essential to understand the technical procedures involved with the acquisition and processing of the heart beat signal obtained through ultrasound or direct electrocardiography (6). The cardiotocographic equipment has been improved markedly since the introduction of cardiotocography. Nevertheless some technical problems have never been fully resolved: some artificial FHR variability, halving and doubling of heart frequencies, recording of cardiac arrhythmias and recording of the maternal instead of the fetal heart frequency. The major problems, though, occur in clinical practice. There is no uniform opinion regarding the preferred paper speed. Recording speeds vary from 1 to 2 to 3 centimetres per minute, depending on the obstetric unit. A low paper speed facilitates the overview of a recording but has predominant disadvantages: ‘long-term’ FHR variability is artificially accentuated, ‘short-term’ variability is hardly recognisable and the time-relation between uterine contractions and decelerations is more difficult to assess.

The many influences of the FHR pattern

The healthy near-term fetus demonstrates a characteristic FHR pattern with continuous cycling of a ‘reactive’ and a ‘non-reactive’ FHR pattern representing the cycling of the sleep states 2F (REM sleep, active sleep) and 1F (non-REM-sleep, quiet sleep) (7). This cycling is interspersed, in particular around midnight with periods of fetal activity (‘jogging’) accompanied by recurrent accelerations sometimes mimicking fetal tachycardia. The maximum duration of a 1F state is 45 minutes in a healthy fetus.

When pregnancy advances accelerations increase in number, duration and amplitude. Variability increases during the 2F states, but is nearly constant after 26 weeks gestational age in 1F state (8). The variability in the 1F states primarily relates to the absence or presence of clusters of regular mouthing movements (associated with oscillations!) or breathing movements (associated with short term variability!) (9). FHR variability may vary from day to day and week to week in the individual fetus (8).

Interpretation of a cardiotographic tracing is particularly difficult early preterm. Generally the decision to start cardiotocography is determined by a serious obstetric problem such as presence of intrauterine growth retardation, rupture of membranes, vaginal blood loss or pregnancy induced hypertension. Interpretation then is not only more difficult because of the age of the fetus and the presenting obstetric problem, but moreover also because of the use of maternally administered medication. Betamimetics increase the baseline FHR and are associated with a decrease in FHR variability. Magnesium sulfate(Drug information on magnesium sulfate) causes a decrease in FHR variability. Antihypertensives may cause tachycardia, bradycardia, flattening of the accelerations or a decrease in variability. Bethamethasone, contrary to dexamethasone(Drug information on dexamethasone), leads to a decrease in the incidence of fetal body and breathing movements and concomitantly a decrease in the number of accelerations and diminished variability (10).

High intra- and inter-observer variability

Reading, classification and interpretation should be the successive steps in the assessment of cardiotocographic tracings. Often too easily a conclusion is reached in (vague) terms of a suspicious, pathologic, ominous or terminal FHR pattern.

The high intra- and inter-observer variability concerning the classification and interpretation of FHR patterns has been substantiated in a large number of publications. Assessment of the baseline frequency and the presence or absence of accelerations and decelerations is rather uniform, but lacks any uniformity when FHR variability and deceleration types are concerned (11). Easy, exact guidelines as to how to determine and to interpret FHR variability are lacking. It appears that in daily obstetric practice variable decelerations far too often are classified as early or late decelerations, merely on the basis of the time-relation between the associated uterine contraction and the deceleration. The typical characteristics of the variable decelerations is that they vary in shape, duration and depth and on this basis nearly all decelerations occurring during labour should be classified as being of the variable type (12). The ‘shouldering’, i.e. the increase in FHR prior to and following a variable deceleration, can incorrectly be interpreted as an acceleration. Their monotonous and recurrent character is, though, very different from the irregularly spaced accelerations occurring in association with fetal body movements. Recurrent increases in the fetal heart rate during uterine contractions should raise suspicion that the (umbilical) venous circulation is being obstructed.

The low validity, high false-positive rate

The low validity of cardiotocography is concluded from a very limited number of earlier performed randomised studies, in which cardiotocography has been compared with intermittent auscultation. These studies suffer from a number of serious drawbacks and inadequacies concerning patient selection, sample size, randomisation procedures, in- and exclusion criteria, the knowledge of the responsible obstetricians how to classify and interpret cardiotocographic tracings and the comparability of the applied intermittent auscultation with daily obstetric practice (dedicated nurses participated in the auscultation groups).

A major problem with these and other studies aiming to assess the validity of cardiotocography and related procedures is the lack of solid endpoints concerning the fetal condition. One of the few hard endpoints is the status of the acid-base balance in arterial and venous cord blood, often applied to assess justification of artificial deliveries for reasons of suspected fetal distress. The primary aim of obstetric interventions in this regard is, though, to prevent fetal distress and as such these measures are not very helpful to assess adequacy of obstetric management in individual cases.

Cardiotocography increases medico-legal vulnerability

Sonography and cardiotocography have been named as the ‘minefields of obstetrics’. In contrast to antepartum monitoring it is the intrapartum application of cardiotocography which may lead to litigation. The knowledge that their baby was in a good condition at the start of the birthing process is for parents an unbearable thought when the baby suffers from handicaps in later life which may possibly relate to the occurrence of fetal distress during the process of labour and delivery. The consumers, supported by legal experts, expect from the obstetrician not so much that she/he diagnoses fetal distress, but on the contrary that a serious threat of the fetal condition is being avoided, certainly if it concerns a child with full potentials for later life. The layman wonders why obstetricians do not all apply the same monitoring techniques and cannot understand why fetal heart rate patterns cannot be classified and interpreted uniformly.

The medico-legal vulnerability associated with the application of cardiotocography and other monitoring techniques is a very complex area. Many aspects are involved, such as the time path followed, the standard of care at a certain moment, the preceding training experienced, the chain of commands at a certain moment, the limitations from merely indirect information, uncertainty when damage to the infant occurred, the confusing nomenclature in use and the lack of exact definitions and guidelines. Nearly all cases are discussed ‘in retrospect’ knowing the fatal result of a particular case. Laymen have little understanding of peak loads in clinical care, the time span necessary before conclusions can reasonably be reached and the intensity of communication prior to a secondary caesarean section. The consumers demand optimal care at each moment in order to maximise future potentials for their child. They exert more and more pressure on decision making and easily push for a caesarean section when the condition of their child might be endangered.

Cardiotocography leads to an increase in obstetric interventions

One of the objections towards electronic fetal monitoring is that the widespread application has induced an increase in the number of obstetric interventions, in particular the incidence of caesarean sections. Randomised studies in the seventies and early eighties have demonstrated a higher incidence of artificial deliveries when cardiotocography was compared with (dedicated) intermittent auscultation. This was especially apparent when FHR monitoring was applied in low risk pregnancies. The adding of microblood sampling as a second mode of fetal surveillance, to assess the fetal acid-base status in case of suspicious or abnormal FHR patterns, clearly reduces the number of obstetric interventions if compared with the application of cardiotocography alone.

Following the introduction of cardiotocography, though, obstetrics and maternal-fetal medicine has developed in a different direction. Certain changes in attitudes of the profession and the public have favoured the obstetric intervention through a certain section such as there are: a shift towards a far lower gestational age at which all is done to increase chances for fetal survival and diminished neonatal morbidity, another approach towards the fetus in breech position both preterm and term, an increase in the maternal age for the first pregnancy, an increase in the number of twins and triplets, another look at the pain experienced by the mother during labour and delivery, other criteria for the duration of the birthing process etc. The main line in obstetric policies has moved towards prevention of serious maternal and fetal risks in whatever circumstances. Large randomised studies in high-risk populations and a recent meta-analysis provide evidence of an approximate 60% reduction in perinatal mortality due to fetal distress when electronic fetal monitoring is applied as a routine in high-risk groups (14). These and other studies support earlier recommendations to apply cardiotocography in risk groups. Risks with a potential impact on the condition of the fetus may be identified already previous to pregnancy (hypertension, diabetes), may show up during the course of pregnancy (vaginal blood loss, early preterm rupture of membranes) or may occur during the process of labour and delivery (meconium staining, FHR decelerations). An anticipative attitude of the obstetrician taking care of the pregnant mother should always be warranted.

The future of cardiotocography

Cardiotocography was initially introduced merely on an empirical basis. At the start little was understood of the (patho-)physiology at the basis of the FHR pattern, the many factors influencing the shape of the FHR pattern and the clinical implications to be drawn from ‘abnormal’ FHR patterns. A classic example is the pseudo-sinusoidal pattern related to fetal sucking which for long was not distinguished from the truly sinusoidal pattern associated with serious fetal anaemia or severe fetal acidosis. The simultaneous introduction of guidelines how to classify and interpret FHR patterns by outstanding obstetricians living at different continents (Caldeyro Barcia, Hammacher, Hon, Maeda, Wood) has further contributed to the confusion in nomenclature and definitions, a problem which has not been resolved in world-wide terms until today.

In spite of many efforts, improvements in the quality of the instrumentation, better understanding of the FHR patterns and improved recognition of the position of cardiotocography among the full arsenal of fetal surveillance techniques, the current status of cardiotocography is at the awkward age. It certainly has not reached full maturity yet. The major weaknesses are formed by its application. Differences in paperspeed, lack of uniform and exact definitions, uncertainties regarding how, when and whom to monitor, problems with storage of cardiotocographic tracings, uncertainty if and when fetal microblood sampling should be applied, the generally very limited training of them who are directly involved with fetal monitoring and the lack of guidelines how to handle in the great variety of (often complex) clinical circumstances are just a few of the problems which have weakened the position of cardiotocography as a monitoring technique. Another aspect is the department’s organisation regarding responsibilities at various locations, i.e. the outpatient clinics, the antenatal clinics and the labour and delivery unit? Are there solid and uniform arrangements and can one trust that they are continuously followed by each and any member of the department?

A computerised system permitting digital processing and storage of all fetal heart rate data has a number of potential advantages: the availability of quantified information including analysis of trends, easy retrieval of relevant cardiotocographic traces for education purposes, decreased medico-legal vulnerability concerning lost CTG traces etc. The currently available integration of a number of fetal (heart rhythm, oxygen saturation) and maternal (heart rhythm, electrocardiogram, oxygen saturation, blood pressure) variables in one monitor offers more possibilities for fetal monitoring in future, in particular studies of the effects of changes in the maternal cardiovascular status on the condition of the fetus. There are initial experiences with management supporting systems in which clinical, biophysical and biochemical data of the mother and the fetus are integrated. These systems still have a long way to go, but certainly deserve further study.

Cardiotocography in itself is a useful and indispensable adjunct to monitor the condition of the (endangered) fetus. In this regard the continuous debate concerning its usefulness compared with intermittent auscultation is meaningless. Both methods in principle provide similar information. However, cardiotocography in comparison with intermittent auscultation results in continuous versus spot-like, and objective versus subjective data.

 


TABLE 1: CRITICISMS TOWARDS CARDIOTOCOGRAPHY

  • insufficient understanding of the (patho-)physiologic background
  • a too indirect signal of the fetal condition
  • a number of technical pitfalls
  • differences in recording techniques
  • primarily qualitative information (pattern recognition)
  • lack of uniform classification systems
  • confusion due to the many influences on the fetal heart rhythm
  • substantial intra- and inter-observer variation regarding the interpretation
  • low validity, high incidence of false-positive findings
  • primarily screening method, too often applied as a diagnostic
  • leads to an increase in artificial deliveries
  • lack of agreement on how, when, and whom to monitor
  • contributes to medico-legal vulnerability

TABLE 2: IMPROVEMENTS IN CARDIOTOCOGRAPHY

  • a further understanding of (patho-)physiology
  • knowledge of technical pitfalls
  • uniform paper speed, vertical scaling
  • knowledge of the many factors influencing FHR patterns
  • knowledge of all relevant clinical data
  • discipline in reading, classification and interpretation of FHR patterns
  • recognition that cardiotocography is an indirect parameter of fetal condition
  • recognition that cardiotocography is only one parameter of fetal condition
  • recognition that cardiotocography is only a screening technique
  • disposition of maximal possible information (microblood sampling)
  • availability of protocols how, when and whom to monitor
  • availability of quantified, objective FHR analyses
  • digital storage of fetal heart rate data
  • systematic pre- and postgraduate training

 

 

Join the Conversation

Want to join the conversation? Just sign in or register today to become part of our growing, online community.





REFERENCES
1. De Snoo K. Leerboek der Verloskunde. Wolters Uitgeversmaatschappij Groningen, 1946
2. Sureau C. The history of fetal surveillance. In: HP Van Geijn, F.J.A. Copray (eds): A critical appraisal of fetal surveillance. Excerpta Medica, Elsevier, Amsterdam 1994: 3-10
3. Rooth G, Huch A, Huch R. Guidelines for the use of fetal monitoring. Int. J. Gynecol. Obstet. 1987; 25: 159-67
4. Van Ravenswaay-Arts CMA, Kollee LAA, Hopman JCW, Stoelinga GBA, Van Geijn HP. Heart rate variability; clinical applicability in adults. Annals Internal Medicine 1993; 118: 436-47
5. De Haan HH, Gunn AJ Gluckman PD. Fetal heart rate changes do not reflect cardiovascular deterioration during brief repeated umbilical cord occlusions in near-term fetal lambs. Am J Obstet Gynecol 1997; 176: 8-17
6. Van Geijn HP. Developments in CTG Analysis. Bailliere’s Clin Obstet Gynaecol; Intrapartum Surveillance 1996; 10-2: 185-209
7. Nijhuis JG. Fetal behaviour: development and perinatal aspects. Oxford University Press,Oxford 1992
8. Mantel R, Van Geijn HP, Ververs IAP, Colenbrander GJ, Kostense PJ. Automated analysis of antepartum fetal heart rate in relation to fetal rest-activity states: a longitudinal study of uncomplicated pregnancies using the Sonicaid System 8000. Eur J Obstet Gynecol Reprod Biol 1996; 71: 41-51
9. Van Woerden EE, Van Geijn HP, Swartjes JM, Caron FYM, Brons JTY, Arts NFTh. Fetal heart rythms during behavioural state 1F. Eur J Obstet Gynaecol Reprod Biol 1988; 28: 29-38
10. Mulder EJH, Derks JB, Zonneveld MF, Bruinse HW, Visser GHA. Transient reduction in fetal activity and heart rate variation after maternal betamethasone administration. Early Human Development 1994; 36: 49-60
11. Donker DK, Hasman A, Van Geijn HP. Interobserver variation in the assessment of fetal heart rate recordings. Eur. J. Obstet. Gynecol. Reprod. Biol. 1993; 52: 21-28
12. Van Geijn HP, Dekker GA, De Vries JIP, Van Vugt JMG. Fetal heart rate patterns during labour. In: HP Van Geijn, F.J.A. Copray (eds): A critical appraisal of fetal surveillance. Excerpta Medica, Elsevier, Amsterdam 1994: 238-270
13. Van Geijn HP. Some reflections on fetal surveillance. In: HP Van Geijn, F.J.A. Copray (eds): A critical appraisal of fetal surveillance. Excerpta Medica, Elsevier, Amsterdam 1994: 659-74
14. Gardosi J. Monitoring technology and the clinical perspective. Bailliere’s Clin Obstet Gynaecol; Intrapartum Surveillance 1996; 10-2: 325-40


TopicIndex

 

Adhesions
Breast Health and Breast Care
Contraception
Electronic Health Records (EHRs)
Endometriosis
Fetal Monitoring
Fibroids
Gestational Diabetes
Gynecologic Oncology
Hysterectomy
Infertility
In Vitro Fertilization (IVF)
Laparoscopy
Malpractice

  Menopause
Osteoporosis

Polycystic Ovary Syndrome
Postpartum Depression
Pelvic Pain
Premenstrual Syndrome/Premenstrual Dysphoric Disorder (PMS/PMDD)
Pregnancy and Birth
Sex-related Issues
Ultrasound
Urogynecology
Uterine (Endometrial) Polyps
Weight Management
Young Women

 

MedicaForums

App to compute fetal weight percentiles
Medica Forums - 5/23/13
Hello,

Has anyone tried FetalGrowth app (App Store for iPhone/iPad) ? I'm interested in using a simple and handy tool to calculate fetal percentiles, and I came across this app, which seems it does the job (plots growth charts, as well). I haven't seen anything else, besides this app, so I was wondering if there are people who have already tried it.

Thanks !
Atypical endometrial cells
Medica Forums - 5/19/13
Had a case the other day with the above finding on a pap. She was age 36 and had a Mirena in place. How do people feel about the idea of trying to do an EMB with an IUD in place? If not, how do we proceed?
Welcome to the new ObGyn.net Forum!
Medica Forums - 5/12/13
Welcome to the new ObGyn.net Forum!

To all the members of OB-GYN-L… Thank you for coming! I’m thrilled that you’ve decided to check out the new Forum site, and look forward to reading about what’s on your mind.

If you’re new to the ObGyn.net community... welcome aboard! You’ve just joined an outstanding group of physicians and health care professionals who have been sharing information, answering questions, and building professional relationships via the site’s listserv for nearly 20 years.

Feel free to poke around on the site to get a feel for things, or take a look at the Help Topics page for instructions on how to use the different features of the site.

A few quick tips:
For those of you who like getting new Forum messages delivered directly to your inbox, the first thing you’ll want to do is click on the ‘Follow this forum’ button on the main page. You’ll have the option of getting notifications immediately, as a daily digest, a weekly digest, or only when you’re not online (which is to say, if you’re on the site when someone posts a message, you won’t be notified of it). You won’t be able to post on the site just by replying to the email, but the message will contain a link that takes you directly to the message you’d like to reply to.

You can also follow individual conversations without following the whole list by going into the topic and clicking the ‘Follow this topic’ button next to the title.

Also, in ‘My Profile’ you can:
  • Enter your professional information, including specialty, subspecialty, and education (by clicking ‘Edit my profile’)
  • See your activity on the Forum, such as what discussions you have initiated or replied to, content you’ve ‘liked,’ and activity of people you’ve made your friends
In ‘My Settings’ you can:
  • Add or change your photo
  • Edit your birthday, gender, interests, location
  • Create a signature for your posts
  • Change the types of content you get notifications for, or change the way you receive notifications
If you have questions, feel free to respond to this post or send me a direct message by clicking on the envelope icon.

Happy posting!
Retained Placenta (Ronald Ainsworth – February 2013)
Medica Forums - 5/11/13
I helped another physician with removal of a retained placenta last night, we were unsuccessful in removing it vaginally, her cervix was too closed to allow manual removal and we could only get a few pieces out with ring forceps and a large curette, so we did a laparotomy/hysterotomy and were able to preserve the uterus. The placenta turned out not to be an accreta and it was easily removed via that route through a low vertical incision on the uterus. Any thoughts on the appropriate CPT code would be appreciated. The patient came in through the ER five days after home delivery by her husband. She was severely anemic, rcvd 7 units of blood and is still quite ill and in the ICU but improving.

Ronald E. Ainsworth, MD, FACOG
Attendance in L and D
Medica Forums - 4/15/13
Recently, I had the occasion to review a case of a term primigravida with PROM in a private hospital (no housestaff or in house obstetricians). She was seen by an obstetrician soon after arrival, evaluated, and pitocin induction begun.

She did not deliver for around 29 hours after admission, and the delivering obstetrician (a different physician) was physically present during the last 2 hours of labor prior to delivery.

Simply put, while the two involved obstetricians were in communication by phone with the nursing staff throughout labor (separately as their "shifts" did not overlap), no one actually came to the bedside and wrote a note) from admission until around 2 hours before delivery.

Medical staff bylaws call for a daily progress note; this bylaw was easily met.

In reviewing the case, it did not "feel good" that no one came to the bedside.

My questions:

1. Does anyone have or know of any guidelines to mandate such bedside attendance? Of course, we all hope that the involved physicians would not need said guidelines.
2. Does anyone have a suggestion of hospital/nursing protocols? Simply, in this case I would like to have had a charge nurse or bedside nurse simply say, "Hey, no one has been by for a while. What's up?"

Garry
Basic Textbooks for an Ob/Gyn resident
Medica Forums - 4/12/13
Hey, what textbooks would you advise for my son who is beginning residency this summer?

Post here or email privately if better.

Thanks,

Garry
Facelift cost
Medica Forums - 4/8/13
<p>Hello  friends ,

           I want to know how much does a facelift cost on average? Do you know anyone what is facelift cost ? please help me .........
Cosleeping Survey help
Medica Forums - 4/7/13
Hello,

I really need help from OB/GYNs and I'm having a hard time getting it. I find your opinions really valuable. I'm researching recommendations for cosleeping. This is for my dissertation, so your time is truly appreciated! Please complete the full survey. It will help me tremendously.

The study takes about 5 to 10 minutes to complete. Please don't hesitate to contact me at bhamel@pacificu.edu with any questions.

If you are interested in participating, please follow the link provided below:

https://www.surveymonkey.com/s/Cosleeping

Thank you in advance for your time. If possible, please forward this to other OB/GYNs you know.

Sorry if this an innappropriate use of the forum. But it seems like the right place to find the participants I need.
Those Wonderful And Useful EMRs
Medica Forums - 4/7/13
.

Our hospital bought an electronic medical record (EMR) system for the clinics. There is a large hosptial group practice including pediatrics, medicine, FP, OB/GYN, and other specialities and sub-specialities. Furthermore, the hospitalists and the ER doctors are also employed in the same hosptial group practice.

The hospital spent millions of dollars on an EMR. As best I can tell there are only two useful things that the EMR does. One is to automatically calcualte the BMI, which it does very well. THe other is to make records available on any patient to any doctor anywhere in the practice. It does not do this well -- it requires lots of mouse movements and clicks and different documents come up in different formats, making it labor intenisve. But, with enough time, effort, and frustration, one can obtain copies of every document in the sustem, either on a computer screen or on paper.

Swith to the ER now. A paitnet whom I had seen the previous week in consultatio comes into the ER for a non-pregnancy problem. They call me on the telephone in the evening. "No problem", I say. I did a torough evaluation and wrote a detailed note on the patient and her OB and non-OB problems only a few days ago. "Just go to the EMR and you can print out my note with all the details."

Seems, however, that for some reason the EMR is not available in the ER (or on the wards for that matter). When I asked the hosptial administrator about it the next morning, he said that he and the hosptial lawyers were working on the problem.

Apparently the government thinks that the ER doctors and hospitalists have nothing better to do with their time than to print out copies of patients' medical records from the EMR and sell them on the black market. Therefore, we cannot let those nasty doctors have access to the EMR records. Nevermind that the ER doctors are in the same group practice as all the other doctors. Never mind that the patient is willing to sign a release so that the doctor who is taking care of her can see the records of the practice. We have to protect the patient even if it means that vital information is rendered unavailable and that things are made more difficult, complicated, and expensive. It reminds me of the Army in Viet Nam where they would have to "destroy a village in order to save it!" Apparently the EMR makes us destroy a patient in order to save her.

Thank GOD for the EMR. Three million dollars and the only benefit is that we can get a BMI 10 seconds faster.

I think the NEJM got it correct last month when they said in an atricle that the only ones who truly benefit from electronic medical record systems are the people who make and sell them.



Dean Huffman
Decline in Semen Concentration.
Medica Forums - 4/7/13
Decline in Semen Concentration and Morphology in a Sample of 26,609 Men Close to General Population Between 1989 and 2005 in France


http://www.medscape....22498EV&spon=16

EducationalTutorials


Fetal Abdomen with Gallbladder Calculi
September 27, 2011

B mode and 3D Ultrasound images of a fetal abdomen (35wks) revealing gallbladder calculi

Sacrococcygeal Teratoma?
September 14, 2011

This case study shows a 26 week gestation with a cystic mass close to the sacrum.

Fetal Cardiac Anomalies
July 19, 2011

CC is a 31 year old primigravida who was referred for ultrasound at a community hospital due to suspected cardiac anomalies noted on a screening sonogram at her doctor's office. Due to concern about a probable cardiac abnormality an amniocentesis was performed at the local hospital.

Single Umbilical Artery Color Doppler
June 15, 2011

Single umbilical artery color doppler, transverse scan of urinary bladder shows single umbilical artery (left), transverse section of umbilical cord showing only two vessels: one vein and one artery (right).

Ductus Venosus Spectral Waveform
June 15, 2011

Normal 35 week pregnancy

CaseStudies


Fetal Abdomen with Gallbladder Calculi
Dr. Muktachand and Dr. Trupti , September 27, 2011

B mode and 3D Ultrasound images of a fetal abdomen (35wks) revealing gallbladder calculi

Sacrococcygeal Teratoma?
Dr. Jaydeep , September 14, 2011

This case study shows a 26 week gestation with a cystic mass close to the sacrum.

Fetal Cardiac Anomalies
Joshua Abbott Copel, MD OBGYN.net Advisory Board Member , July 19, 2011

CC is a 31 year old primigravida who was referred for ultrasound at a community hospital due to suspected cardiac anomalies noted on a screening sonogram at her doctor's office. Due to concern about a probable cardiac abnormality an amniocentesis was performed at the local hospital.

Single Umbilical Artery Color Doppler
Abana Cerekja , June 15, 2011

Single umbilical artery color doppler, transverse scan of urinary bladder shows single umbilical artery (left), transverse section of umbilical cord showing only two vessels: one vein and one artery (right).

Ductus Venosus Spectral Waveform
Dr. Joe Antony , June 15, 2011

Normal 35 week pregnancy

FromPhysiciansPractice

Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

  • On This Site
  • Most Emailed
  • On This Topic

MostPopular

  • DailyDx: A 12-Week Fetus

    APR 23 2013 OBGYN.NET READ >>

  • Daily Dx: Young Lady with Abdominal Pain

    MAY 1 2013 OBGYN.NET READ >>

  • Daily Dx: Pelvic Pain with Discharge

    MAY 7 2013 OBGYN.NET READ >>

  • The Relationship Between Placental Location and Fetal Gender (Ramzi’s Method)

    JUN 14 2011 OBGYN.NET READ >>

  • Endometrial Polyps

    JUN 21 2011 READ >>

MostPopular

  • Prophylactic Progesterone May Be Harmful in Twin Pregnancies

    MAY 8 2013OBGYN.NET READ >>

  • Early Surgically-Induced Menopause Linked with Cognitive Decline

    MAY 9 2013OBGYN.NET READ >>

  • The Relationship Between Placental Location and Fetal Gender (Ramzi’s Method)

    JUN 14 2011OBGYN.NET READ >>

  • Postsurgical Levonorgestrel IUD Improves Endometriosis Symptoms

    APR 24 2013OBGYN.NET READ >>

  • Ob/Gyns Should Offer Long Acting Reversible Contraception First to Lower Unintended Pregnancy Rates

    MAY 9 2013OBGYN.NET READ >>

MostPopular

  • Electronic Fetal Monitoring

    AUG 16 2011 OBGYN.NET READ >>

  • Adding ST Analysis Improves Electronic Fetal Monitoring

    APR 22 2013 OBGYN.NET READ >>

  • Fetal Monitoring

    SEP 21 2006 OBGYN.NET READ >>

  • The Pitfalls of Fetal Monitoring

    SEP 15 2006 OBGYN.NET READ >>

  • Fetal Monitoring by ECG and Fetal Defense Mechanisms

    SEP 21 2006 OBGYN.NET READ >>

  • Popular
  • Recent

Comments

  • Does Controlled Cord Traction Reduce Postpartum Blood Loss?

    MAY 10 2013 OBGYN.NET READ >>

  • Daily Dx: Fetal Quiz

    JAN 15 2013 OBGYN.NET READ >>

  • Daily Dx: Severe Pelvic Pain in Third Trimester

    OCT 2 2012 OBGYN.NET READ >>

  • Sacrococcygeal Teratoma?

    SEP 14 2011 OBGYN.NET READ >>

  • DailyDx: What is the Diagnosis of this Hyperemia Uterus?

    OCT 25 2011 OBGYN.NET READ >>

Comments

  • Scholarly Debate

    JUN 22 2011 READ >>

  • DailyDx: What is the Diagnosis of this Hyperemia Uterus?

    OCT 25 2011 OBGYN.NET READ >>

  • IUDs Are Effective Emergency Contraception

    MAY 18 2012 OBGYN.NET READ >>

  • Prophylactic Progesterone May Be Harmful in Twin Pregnancies

    MAY 8 2013 OBGYN.NET READ >>

  • Does Controlled Cord Traction Reduce Postpartum Blood Loss?

    MAY 10 2013 OBGYN.NET READ >>

 

 

 

SearchMedicaSearchResult

Find peer-reviewed literature and websites for practicing medical professionals

CME on Fetal Monitoring
Evidence on Fetal Monitoring
Guidelines on Fetal Monitoring
Patient Education on Fetal Monitoring
Clinical Trials on Fetal Monitoring
Practical Articles on Fetal Monitoring
Research and Reviews on Fetal Monitoring
All "Fetal Monitoring" results

EventCalendar

  • The 5th IVI International Congress: Reproductive Medicine and Beyond by ComtecMed
    04-Apr-13 to 06-Apr-13 Seville , SPAIN (GYN - Contraception & Reproductive Health)
     
  • 2013 AIUM Annual Convention by American Institute of Ultrasound in Medicine
    06-Apr-13 to 10-Apr-13 New York (New York Marriott Marquis Hotel) , NY USA (CME - Medical Education)
     
  • Manejo clínico y terapéutico de la esterilidad. Segundo curso online by Fundacio Dexeus Salud de la Mujer
    09-Apr-13 to 31-May-13 online , SPAIN(gynecology)
     
  • Pediatric Nursing: Care of the Hospitalized Child by Continuing Education Inc.
    10-Apr-13 to 13-Apr-13 Anaheim (Hyatt Regency Orange County) , CA USA (CME - Obstetrics, Gynecology & Women's Health)
     
  • Medicina fetal Curso-Taller. Curso de Nivel I y II de la SESEGO by Fundacio Dexeus Salud de la Mujer
    15-Apr-13 to 17-Apr-13 Barcelona (Auditorio Salud de la Mujer Dexeus) , SPAIN (OB - Maternal Fetal Medicine)
     
  • Female Urology & Urogynecology Symposium (FUUS) by Quadrant HealthCom, Inc
    18-Apr-13 to 20-Apr-13 Las Vegas (ARIA) , NV USA (CME - Obstetrics, Gynecology & Women's Health)
     
  • Female Urology and Urogynecology Symposium (FUUS) 2013 by Quadrant HealthCom, Inc
    18-Apr-13 to 20-Apr-13 Las Vegas (ARIA) , NV USA (CME - Obstetrics, Gynecology & Women's Health)

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy